Veozah is an NK3 receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Veozah is an NK3 receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
If you have a Hayes login, click here to view the full report on the Knowledge Center.